Chiesi USA: Elevating the experience of managing each patient’s condition.
Chiesi USA is committed to developing and commercializing products that meet the needs of healthcare providers and their patients. We deliver our products and associated services to improve the treatment of patients.
We are also dedicated to investing in research and development initiatives that deliver value-added medical solutions in our current therapeutic areas as well as other therapeutic areas where the need exists.
(To download the following documents, you will need Adobe Acrobat installed on your computer. Click here to download Adobe Acrobat.)
ARGATROBAN for Injection, 50 mg per mL
CUROSURF® (poractant alfa) Intratracheal Suspension
ZYFLO® (zileuton) Tablets